| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |